HELIXNCT06948773
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria shortened, about 3 words
- Trial completed
- Primary and study completion dates changed from estimate of Sep 30, 2026 to Sep 7, 2026
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Minor Start date changed from estimate of May 30, 2025 to May 21, 2025v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Apr 30, 2025 to May 30, 2025
- Site details revised
- Notable Primary endpoint revised
- Study title revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
≥ 20% change from baseline in mean IOP at the 3-month post-operative endpoint
Timeframe: 3 months
Secondary (2)
Change in mean IOP
Average number of ocular hypotensive medications
Arms and interventions
POAG and CataractsExperimental
Subjects diagnosed with mild to moderate primary open angle glaucoma (POAG) and cataracts in the study eye.
Devices: Helix Surgical System
Sites
1 site in 1 country
- Panama Eye CenterPanama City, Panama